135 related articles for article (PubMed ID: 24686558)
1. Structure activity relationship of brevenal hydrazide derivatives.
Goodman A; McCall JR; Jacocks HM; Thompson A; Baden D; Abraham WM; Bourdelais A
Mar Drugs; 2014 Mar; 12(4):1839-58. PubMed ID: 24686558
[TBL] [Abstract][Full Text] [Related]
2. Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays.
Bourdelais AJ; Campbell S; Jacocks H; Naar J; Wright JL; Carsi J; Baden DG
Cell Mol Neurobiol; 2004 Aug; 24(4):553-63. PubMed ID: 15233378
[TBL] [Abstract][Full Text] [Related]
3. A new polyether ladder compound produced by the dinoflagellate Karenia brevis.
Bourdelais AJ; Jacocks HM; Wright JL; Bigwarfe PM; Baden DG
J Nat Prod; 2005 Jan; 68(1):2-6. PubMed ID: 15679307
[TBL] [Abstract][Full Text] [Related]
4. Airway responses to aerosolized brevetoxins in an animal model of asthma.
Abraham WM; Bourdelais AJ; Sabater JR; Ahmed A; Lee TA; Serebriakov I; Baden DG
Am J Respir Crit Care Med; 2005 Jan; 171(1):26-34. PubMed ID: 15447946
[TBL] [Abstract][Full Text] [Related]
5. Development of a fluorescence assay for the characterization of brevenal binding to rat brain synaptosomes.
McCall JR; Goodman AJ; Jacocks HM; Thompson AM; Baden DG; Bourdelais AJ
J Nat Prod; 2014 Sep; 77(9):2014-20. PubMed ID: 25226846
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.
Truxal LT; Bourdelais AJ; Jacocks H; Abraham WM; Baden DG
J Nat Prod; 2010 Apr; 73(4):536-40. PubMed ID: 20218657
[TBL] [Abstract][Full Text] [Related]
7. Brevenal, a brevetoxin antagonist from Karenia brevis, binds to a previously unreported site on mammalian sodium channels.
Gold EP; Jacocks HM; Bourdelais AJ; Baden DG
Harmful Algae; 2013 Jun; 26():12-19. PubMed ID: 23789024
[TBL] [Abstract][Full Text] [Related]
8. Natural and derivative brevetoxins: historical background, multiplicity, and effects.
Baden DG; Bourdelais AJ; Jacocks H; Michelliza S; Naar J
Environ Health Perspect; 2005 May; 113(5):621-5. PubMed ID: 15866774
[TBL] [Abstract][Full Text] [Related]
9. Variation in brevetoxin and brevenal content among clonal cultures of Karenia brevis may influence bloom toxicity.
Errera RM; Bourdelais A; Drennan MA; Dodd EB; Henrichs DW; Campbell L
Toxicon; 2010; 55(2-3):195-203. PubMed ID: 19631681
[TBL] [Abstract][Full Text] [Related]
10. The effect of brevenal on brevetoxin-induced DNA damage in human lymphocytes.
Sayer A; Hu Q; Bourdelais AJ; Baden DG; Gibson JE
Arch Toxicol; 2005 Nov; 79(11):683-8. PubMed ID: 15986201
[TBL] [Abstract][Full Text] [Related]
11. Marine biology. Florida red tide brews up drug lead for cystic fibrosis.
Potera C
Science; 2007 Jun; 316(5831):1561-2. PubMed ID: 17569840
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention.
Abraham WM; Bourdelais AJ; Ahmed A; Serebriakov I; Baden DG
Environ Health Perspect; 2005 May; 113(5):632-7. PubMed ID: 15866776
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, modeling, and biological evaluation of analogues of the semisynthetic brevetoxin antagonist beta-naphthoyl-brevetoxin.
Michelliza S; Abraham WM; Jacocks HM; Schuster T; Baden DG
Chembiochem; 2007 Dec; 8(18):2233-9. PubMed ID: 18000915
[TBL] [Abstract][Full Text] [Related]
14. Chemical analysis of Karenia papilionacea.
Fowler N; Tomas C; Baden D; Campbell L; Bourdelais A
Toxicon; 2015 Jul; 101():85-91. PubMed ID: 25981346
[TBL] [Abstract][Full Text] [Related]
15. Benthic herbivores are not deterred by brevetoxins produced by the red tide dinoflagellate Karenia brevis.
Sotka EE; McCarty A; Monroe EA; Oakman N; Van Dolah FM
J Chem Ecol; 2009 Jul; 35(7):851-9. PubMed ID: 19590925
[TBL] [Abstract][Full Text] [Related]
16. Marine brevetoxin induces IgE-independent mast cell activation.
Hilderbrand SC; Murrell RN; Gibson JE; Brown JM
Arch Toxicol; 2011 Feb; 85(2):135-41. PubMed ID: 20549194
[TBL] [Abstract][Full Text] [Related]
17. Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation.
Tibbetts BM; Baden DG; Benson JM
J Toxicol Environ Health A; 2006 Jul; 69(14):1325-35. PubMed ID: 16760139
[TBL] [Abstract][Full Text] [Related]
18. Brevetoxins 2, 3, 6, and 9 show variability in potency and cause significant induction of DNA damage and apoptosis in Jurkat E6-1 cells.
Murrell RN; Gibson JE
Arch Toxicol; 2009 Nov; 83(11):1009-19. PubMed ID: 19536525
[TBL] [Abstract][Full Text] [Related]
19. Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by
Hort V; Abadie E; Arnich N; Dechraoui Bottein MY; Amzil Z
Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940655
[TBL] [Abstract][Full Text] [Related]
20. A highly convergent approach toward (-)-brevenal.
Crimmins MT; Shamszad M; Mattson AE
Org Lett; 2010 Jun; 12(11):2614-7. PubMed ID: 20446718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
